- Home
- CGEM vs NCDL Comparison
CGEM vs NCDL Comparison
Compare CGEM & NCDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- NCDL
- Stock Information
- Founded
- CGEM 2016
- NCDL 2019
- Country
- CGEM United States
- NCDL United States
- Employees
- CGEM N/A
- NCDL N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- NCDL
- Sector
- CGEM Health Care
- NCDL
- Exchange
- CGEM Nasdaq
- NCDL NYSE
- Market Cap
- CGEM 730.2M
- NCDL 929.5M
- IPO Year
- CGEM 2021
- NCDL N/A
- Fundamental
- Price
- CGEM $12.39
- NCDL $16.76
- Analyst Decision
- CGEM Strong Buy
- NCDL Buy
- Analyst Count
- CGEM 7
- NCDL 6
- Target Price
- CGEM $31.67
- NCDL $18.33
- AVG Volume (30 Days)
- CGEM 546.1K
- NCDL 313.7K
- Earning Date
- CGEM 11-07-2024
- NCDL 02-22-2025
- Dividend Yield
- CGEM N/A
- NCDL 7.98%
- EPS Growth
- CGEM N/A
- NCDL N/A
- EPS
- CGEM N/A
- NCDL N/A
- Revenue
- CGEM N/A
- NCDL N/A
- Revenue This Year
- CGEM N/A
- NCDL N/A
- Revenue Next Year
- CGEM N/A
- NCDL N/A
- P/E Ratio
- CGEM N/A
- NCDL N/A
- Revenue Growth
- CGEM N/A
- NCDL N/A
- 52 Week Low
- CGEM $10.00
- NCDL $16.00
- 52 Week High
- CGEM $30.19
- NCDL $18.10
- Technical
- Relative Strength Index (RSI)
- CGEM 47.96
- NCDL 38.58
- Support Level
- CGEM $11.75
- NCDL $16.50
- Resistance Level
- CGEM $12.95
- NCDL $17.15
- Average True Range (ATR)
- CGEM 0.76
- NCDL 0.23
- MACD
- CGEM 0.19
- NCDL -0.03
- Stochastic Oscillator
- CGEM 77.69
- NCDL 29.31
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.
About NCDL NUVEEN CHURCHILL DIRECT LENDNG CORP
Nuveen Churchill Direct Lending Corp is a specialty finance company focused predominantly on investing in senior secured loans to private equity-owned U.S. middle market companies. It invest in senior secured loans that typically pay floating interest rates and are senior in the capital structure to junior debt and equity.